Besides lung cancer, ESCC, melanoma, GC and breast cancer, RICTOR overexpression was also reported in glioblastoma [32, 33], hepatocellular carcinomas [34] and pancreatic ductal adenocarcinoma (PDAC) [35]. This evidence concerns the gene RICTOR and lung carcinoma.